scholarly journals Mutation and gender-specific risk in type 2 long QT syndrome: Implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome

Heart Rhythm ◽  
2011 ◽  
Vol 8 (10) ◽  
pp. 1537-1543 ◽  
Author(s):  
Dimitry Migdalovich ◽  
Arthur J. Moss ◽  
Coeli M. Lopes ◽  
Jason Costa ◽  
Gregory Ouellet ◽  
...  
2010 ◽  
Vol 55 (10) ◽  
pp. A130.E1215
Author(s):  
James A. Kim ◽  
Arthur J. Moss ◽  
Coeli M. Lopes ◽  
Scott McNitt ◽  
Jennifer L. Robinson ◽  
...  

EP Europace ◽  
2016 ◽  
Vol 18 (suppl_1) ◽  
pp. i85-i85
Author(s):  
Yitschak Biton ◽  
Ilan Goldenberg ◽  
Wojciech Zareba ◽  
Kutyifa Valentina ◽  
Arthur J. Moss

Heart Rhythm ◽  
2013 ◽  
Vol 10 (3) ◽  
pp. 378-382 ◽  
Author(s):  
Jamie Mullally ◽  
Ilan Goldenberg ◽  
Arthur J. Moss ◽  
Coeli M. Lopes ◽  
Michael J. Ackerman ◽  
...  

Author(s):  
Asami Kashiwa ◽  
Takeshi Aiba ◽  
Hisaki Makimoto ◽  
Keiko Shimamoto ◽  
Kenichiro Yamagata ◽  
...  

Background - Mutation/variant-site specific risk stratification in long-QT syndrome type 1 (LQT1) has been well investigated, but it is still challenging to adapt current enormous genomic information to clinical aspects caused by each mutation/variant. We assessed a novel variant-specific risk stratification in LQT1 patients. Methods - We classified a pathogenicity of 141 KCNQ1 variants among 927 LQT1 patients (536 probands) based on the American College of Medical Genetics and Genomics (ACMG) and Association for Molecular Pathology (AMP) guidelines and evaluated whether the ACMG/AMP-based classification was associated with arrhythmic risk in LQT1 patients. Results - Among 141 KCNQ1 variants, 61 (43.3%), 55 (39.0%), and 25 (17.7%) variants were classified into pathogenic (P), likely pathogenic (LP), and variant of unknown significance (VUS), respectively. Multivariable analysis showed that proband (HR = 2.53; 95%CI = 1.94-3.32; p <0.0001), longer QTc (≥500ms) (HR = 1.44; 95%CI = 1.13-1.83; p = 0.004), variants at membrane spanning (MS) (vs. those at N/C terminus) (HR = 1.42; 95%CI = 1.08-1.88; p = 0.01), C-loop (vs. N/C terminus) (HR = 1.52; 95%CI = 1.06-2.16; p = 0.02), and P variants [(vs. LP) (HR = 1.72; 95%CI = 1.32-2.26; p <0.0001), (vs. VUS) (HR = 1.81; 95%CI = 1.15-2.99; p = 0.009)] were significantly associated with syncopal events. The ACMG/AMP-based KCNQ1 evaluation was useful for risk stratification not only in family members but also in probands. A clinical score (0~4) based on proband, QTc (≥500ms), variant location (MS or C-loop) and P variant by ACMG/AMP guidelines allowed identification of patients more likely to have arrhythmic events. Conclusions - Comprehensive evaluation of clinical findings and pathogenicity of KCNQ1 variants based on the ACMG/AMP-based evaluation may stratify arrhythmic risk of congenital long-QT syndrome type 1.


2020 ◽  
Vol 30 (8) ◽  
pp. 1171-1172
Author(s):  
Jun Muneuchi ◽  
Yuichiro Sugitani ◽  
Mamie Watanabe

AbstractWe present the case of a 12-year-old boy with type 2 long QT syndrome in whom torsades de pointes was induced by an acute face immersion test. This test is feasible to predict cardiac events in adolescents with long QT syndrome.


Heart Rhythm ◽  
2010 ◽  
Vol 7 (12) ◽  
pp. 1797-1805 ◽  
Author(s):  
James A. Kim ◽  
Coeli M. Lopes ◽  
Arthur J. Moss ◽  
Scott McNitt ◽  
Alon Barsheshet ◽  
...  

2021 ◽  
Vol 15 ◽  
Author(s):  
Caroline Taylor ◽  
Bruce S Stambler

Congenital long QT syndrome (LQTS) is a primary genetic and electrical disorder that increases risk for torsades de pointes, syncope, and sudden death. Post-pubertal women with LQTS require specialized multidisciplinary management before, during, and after pregnancy involving cardiology and obstetrics to reduce risk for cardiac events in themselves and their fetuses and babies. The risk of potentially life-threatening events is lower during pregnancy but increases significantly during the 9-month postpartum period. Treatment of women with LQTS with a preferred β-blocker at optimal doses along with close monitoring are indicated throughout pregnancy and during the high-risk postpartum period.


Sign in / Sign up

Export Citation Format

Share Document